PMID-sentid	Pub_year	Sent_text		comp_official_name	comp_offsetprotein_name	organism	prot_offset
12189523-1	2002	The overexpression of mutant forms of O(6)-methylguanine-DNA-methyltransferase (MGMT), resistant to the MGMT inhibitor O(6)-benzylguanine (BG), protects hematopoietic cells from the toxicity of combined BG plus O(6)-alkylating agent chemotherapy.	o(6)	38-42	O-6-methylguanine-DNA methyltransferase	Mus musculus	80-84	
12189523-1	2002	The overexpression of mutant forms of O(6)-methylguanine-DNA-methyltransferase (MGMT), resistant to the MGMT inhibitor O(6)-benzylguanine (BG), protects hematopoietic cells from the toxicity of combined BG plus O(6)-alkylating agent chemotherapy.	o(6)	38-42	O-6-methylguanine-DNA methyltransferase	Mus musculus	104-108	
11553261-0	2001	Protection of hematopoietic cells from O(6)-alkylation damage by O(6)-methylguanine DNA methyltransferase gene transfer: studies with different O(6)-alkylating agents and retroviral backbones.	o(6)	39-43	O-6-methylguanine-DNA methyltransferase	Mus musculus	65-105	
11553261-2	2001	To identify possible clinical applications of this technology we compared the effect of MGMT gene transfer on the hematotoxicity induced by different O(6)-alkylating agents in clinical use: the chloroethylnitrosoureas ACNU, BCNU, CCNU and the tetrazine derivative temozolomide.	o(6)	150-154	O-6-methylguanine-DNA methyltransferase	Mus musculus	88-92